# Early Feasibility Study - Edwards APTURE Transcatheter Shunt System

> **NCT03523416** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 71 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Transcatheter Atrial Shunt System

## Key facts

- **NCT ID:** NCT03523416
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-07-31
- **Primary completion:** 2023-12-15
- **Final completion:** 2028-11
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03523416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03523416, "Early Feasibility Study - Edwards APTURE Transcatheter Shunt System". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03523416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*